Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
letermovir drospirenone

increases exposure

Unknown Study
letermovir dutasteride

increases exposure

Unknown Study
letermovir elexacaftor

increases exposure

Unknown Theoretical
letermovir encorafenib

increases exposure

Unknown Study
letermovir endothelinreceptorantagonists

increases concentration

Unknown Theoretical
letermovir endothelinreceptorantagonists

increases exposure

Unknown
letermovir entrectinib

increases exposure

Unknown Theoretical
letermovir eplerenone

increases exposure

Unknown Study
letermovir erlotinib

increases exposure

Unknown Study
letermovir fesoterodine

increases exposure

Unknown Study
letermovir fexofenadine

increases concentration

Unknown Theoretical
letermovir finerenone

increases exposure

Unknown Study
letermovir fosphenytoin

decreases concentration

Unknown Theoretical
letermovir gefitinib

increases exposure

Unknown Study
letermovir glibenclamide

increases concentration

Unknown Theoretical
letermovir guanfacine

increases concentration

Unknown Theoretical
letermovir ibrutinib

increases exposure

Unknown Study
letermovir imatinib

increases exposure

Unknown Study
letermovir lapatinib

increases exposure

Unknown Study
letermovir lomitapide

increases exposure

Unknown Theoretical
letermovir macitentan

increases exposure

Unknown Theoretical
letermovir methadone

increases exposure

Unknown Theoretical
letermovir midostaurin

increases exposure

Unknown Theoretical
letermovir mineralocorticoidreceptorantagonists

increases exposure

Unknown Study
letermovir mizolastine

increases exposure

Unknown Theoretical
letermovir mobocertinib

increases exposure

Unknown Study
letermovir naldemedine

increases exposure

Unknown Study
letermovir naloxegol

increases exposure

Unknown Study
letermovir neratinib

increases exposure

Unknown Study
letermovir nilotinib

increases exposure

Unknown Study
letermovir olaparib

increases exposure

Unknown Theoretical
letermovir paclitaxel

increases exposure

Unknown Anecdotal
letermovir pazopanib

increases exposure

Unknown Study
letermovir pemigatinib

increases exposure

Unknown Study
letermovir phenytoin

decreases concentration

Unknown Theoretical
letermovir phosphodiesterasetype-

increases exposure

Unknown Theoretical
letermovir pimozide

increases exposure

Unknown Theoretical
letermovir piperaquine

increases concentration

Unknown Theoretical
letermovir ponatinib

increases exposure

Unknown Study
letermovir quetiapine

increases exposure

Unknown Study
letermovir ranolazine

increases exposure

Unknown Study
letermovir regorafenib

increases exposure

Unknown Study
letermovir ribociclib

increases exposure

Unknown Study
letermovir rimegepant

increases exposure

Unknown Study
letermovir rupatadine

increases exposure

Unknown Study
letermovir ruxolitinib

increases exposure

Unknown Study
letermovir saxagliptin

increases exposure

Unknown Study
letermovir selpercatinib

increases exposure

Unknown Study
letermovir siponimod

increases exposure

Unknown Study
letermovir statins

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.